A new study on glaucoma, a leading cause of irreversible blindness, offers a fresh understanding of how the disease ...

The study by OHSU researchers unlocks potential new treatment options for a leading cause of blindness In a new study, OHSU ...

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the recipient of a significant growth in short interest in March. As ...

The multi‐site VITA trial, a prospective pilot study designed to assess the safety and effectiveness of Avisi Technologies' investigational VisiPlate® device, enrolled and treated 15 subjects ...